Work

Circulating Tumor DNA (ctDNA) Enables Superior and Universal Measurable Residual Disease (MRD) Monitoring in Acute Myeloid Leukemia (AML) Highly Predictive of Relapse Free and Overall Survival

Year: 2024

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2024-201701

Authors: Ruwan Gunaratne, Crystal Zhou, Jesse W. Tai, Sky Kim, Kailee Tanaka, Sanjeeth Rajaram, Mia Carleton, Raymond Yin, Matthew Alkaitis, Matthew Schwede, Brian J. Sworder, Michael S. Khodadoust, Ravi Majeti, David Kurtz, Tian Y Zhang

Institutions: Stanford Medicine, Stanford University, University of California, San Francisco, University of California, Irvine, Stanford Cancer Institute, Institute for Stem Cell Biology and Regenerative Medicine

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405040034

Cites:

Cited by: 5

Related to: 10